Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2013; 59(6): 72-80

Influence of immunocorrection on the inflammatory process in the urogenital tract in men with infertility

Tsiporenko SIu

    Lugansk State Medical University, Lugansk, Ukraine


We studied the concentration of metalloproteinases, pro-and anti-inflammatory cytokines, lymphocyte activation markers in seminal plasma of men with oligosymptomatic forms of chronic inflammation of the urogenital tract complicated with infertility. It was shown that chronic inflammation of the urogenital tract shifts the levels of cytokine profile, reduces the concentration of metalloproteinase-2 (576.4 +/- 89.3 ng/ml, P < 0.001), chemokines - fractalkine (16.3 +/- 1.3 pg/ml, P < 0.001) and chemmmokine regulated by activation, expression and secretion of normal T-cells (RANTES (12.7 +/- 1.0 pg/ ml, P < 0.001). Additionally, we observed a sharp increase in IL-8 (215.5 +/- 7.8 pg/ml, P < 0.01), MCP-1 (926.4 +/- 30.2 pg/ml, P < 0.001) and elevation of the CD25 + / CD95 + ratio. These observations point for alterations in apoptotic mechanisms in pathological forms of the generative cells and their accumulation in the sperm. Prolonged inflammation of the genital area is accompanied by depletion of the local immune system resulting in the development of infertility. The multidirectional shifts in IL-10/IL-12 index have been established: an increase in the group of patients with elevated level of hypercapitated spermatozoa and its reduction in microsomatic morphotype of spermatozoa. These data emphasize the importance of the microenvironment in maturation of gametes. It was shown that an inclusion of alfagin and gepatomax in immunorehabilitation of men with oligosymptomatic forms of urogenital infections improves leukocyte subpopulation content of sperm and concentrations of pro-and anti-inflammatory cytokines, and therefore, results in an increase in fertilizing potential.

Keywords: male infertility, sperm, seminal plasma, metalloproteinases, cytokine profile, immunorehabilitation, alfagin, hepatomax.


  1. Lyah Yu.E., Gur'yanov V.G. Osnovi komp'yuternoi biostatistiki: analiz informatsii v biologii, meditsine ifarmatsii statisticheskim paketom. Donetsk: MedStat, 2004. 212 s.
  3. Orlova L., Petrov S. Aktivnist' metaloproteinazimatriksu (MMR-2) i katepsinopodibnoi proteinaziD u riznih vidiv zmii . Visnik L'viv. un-tu. 2011. N 55. S. 34-38.
  5. Poryadin G.V., Salmasi Zh. M., Kazimirskii A. N. Aktivatsionnie markeri limfotsitov kak pokazatelidisregulyatsii immunnoi sistemi pri vospalenii .Patologiya i terapiya. 2006. N 2. S. 2-7.
  7. Baumgart E., Lenk S,V., Loening S.A., Jung K. Quantitativedifferences in matrix metalloproteinase (MMP)-2, but not inMMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermicpatients . Hum. Reprod. 2002. N 17. R. 2919-2923.
  9. Benjamin M.M., Khalil R.A. Matrix metalloproteinase inhibitorsas investigative tools in the pathogenesis and managementof vascular disease . EXS. 2012. 103. P. 209-279. CrossRef PubMed PubMedCentral
  11. Elkington, P.T., O'Kane, C.M., Friedland, J.S. The paradoxof matrix metalloproteinases in infectious disease . Clin.Exp. Immunol. 2005. 142. P. 12-20. CrossRef PubMed PubMedCentral
  13. Jedinak A., Maliar T. Inhibitors of proteases as anticancerdrugs . Neoplasma. 2005. 52. P. 185-192. PubMed
  15. Jennifer R., Fang Li, Xiaobei Zhang. ELR-CXC chemokinereceptor antagonism targets inflammatory responses atmultiple levels . J. Immun. 2009. 182. P. 3213-3222. CrossRef PubMed
  17. Loetscher, P., Clark-Lewis, I. Agonistic and antagonisticactivities of chemokines . J. Leukoc. Biol. 2001. 69. P. 881-884. PubMed
  19. Marquez-Curtis L.A., Shirvaikar N., Robert Turner A., MirzaI. Membrane type-1 matrix metalloproteinase expressionin acute myeloid leukemia and its upregulation by tumornecrosis factor-? . Cancers. 2012. 4. P. 743-762. CrossRef PubMed PubMedCentral
  21. McCauley T.C., Zhang H.M., Bellin M.E., Ax R.L.Identification of a heparin-binding protein in bovineseminal fluid as tissue inhibitor of metalloproteinases-2.Mol . Reprod. Dev. 2001. 58. P. 336-341. CrossRef  
  22. Pal S., Ganguly K.K., Chatterjee A. Extracellular matrixprotein fibronectin induces matrix metalloproteinases inhuman prostate adenocarcinoma cells PC-3 . Cell Commun.Adhes. 2013. 20(5). P. 105-114. CrossRef PubMed
  24. Papanicolaou G.N. New cancer diagnosis. Proceedingsof the Third Race Betterment Conference, January 1928.Race Betterment Foundation, Battle Creek, Michigan. 1928. P. 528-534.
  26. Seshadri S., Bates M., Vince G., Lewis Jones D. I.Cytokine expression in the seminal plasma and its effectson fertilisation rates in an IVF cycle . Andrologia. 2011. 43. P. 378-386. CrossRef PubMed
  28. Van den Steen P.E., Proost P., Wuyts A., Van DammeJ., Opdenakker G. Neutrophil gelatinase B potentiatesinterleukin-8 tenfold by aminoterminal processing, whereasit degrades CTAP-III, PF-4, and GRO-? and leaves RANTESand MCP-2 intact . Blood. 2001. 96. P. 2673-2681.
  30. WHO laboratory manual for the examination of humansperm and semem-cervical mucus interaction. WHO,4-th edn.: Cambridge universiti press, 1999. P. 128.
  32. Zakosek Pipan M., Kosec M., Mrkun J., Zrimsek P. Gelatinasesin boar seminal plasma and their relation to semenindicators . Acta Vet. 2010. 79. P .491-496.
  34. Zhang X., Ibrahim E., de Rivero Vaccari J.P., Lotocki G.,Aballa T.C. Involvement of the inflammasome in abnormalsemen quality of men with spinal cord injury . Fertil.Steril. 2013. 99. P. 118-124. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.